at Zacks.com (Wed, 8:46AM)
St. Jude Medical (STJ +0.2%) has reportedly pledged to improve training and quality procedures, and correct flaws the FDA found during an inspection of the company's Sylmar facility in California, which manufactures a key heart-rhythm device. The inspection focused on the Durata wires that connect defibrillators to the heart and which have had no end of problems.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Tue, 6:10PM)
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 8, 2015)
at Nasdaq.com (Dec 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs